Preventing autoimmunity after alemtuzumab in multiple sclerosis: regulatory T cells resist expansion

David P J Hunt

doi:10.1093/brain/awag308

CrossrefKarta ta’ informazzjoni

Preventing autoimmunity after alemtuzumab in multiple sclerosis: regulatory T cells resist expansion

David P J Hunt

Brain · 2026-11-04 · 149 (11) · 3681-3682

DOI: 10.1093/brain/awag308 ↗

Astratt Dettalji biblijografiċi

Astratt

This scientific commentary refers to ‘Low-dose IL-2 fails to expand Tregs after alemtuzumab: insight into impaired immune tolerance in multiple sclerosis’, by Georgieva et al. (https://doi.org/10.1093/brain/awag171).

Dettalji biblijografiċi

Awturi/Awturiċi: David P J Hunt
Ġurnal: Brain
Sena tal-pubblikazzjoni: 2026
Volum / Ħarġa: 149 / 11
Paġni: 3681-3682
Pubblikatur: Oxford University Press (OUP)
DOI: 10.1093/brain/awag308
ISSN: 0006-8950; 1460-2156
Sors: Crossref

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.